Antibiotic resistance of conjunctiva and nasopharynx evaluation study: A prospective study of patients undergoing intravitreal injections

Ophthalmology

Volumn 117, Issue 12, 2010, Pages 2372-2378

  Kim, Stephen J ^a   Toma, Hassanain S ^a   Midha, Narinder K ^b   Cherney, Edward F ^a   Recchia, Franco M ^a   Doherty, Terrence J ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY HOSPITAL   (United States)

^c Loden Vision Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; AMOXICILLIN PLUS CLAVULANIC ACID; AZASITE; AZITHROMYCIN; BEVACIZUMAB; CEFAZOLIN; CEFOXITIN; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANIBIZUMAB; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; HUMAN; MALE; NASOPHARYNX; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS LUGDUNENSIS; SUBRETINAL NEOVASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; BACTERIA; CHOROIDAL NEOVASCULARIZATION; CONJUNCTIVA; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NASOPHARYNX; PROSPECTIVE STUDIES;

EID: 78649804238     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.03.034     Document Type: Article

References (43)

1. R.D. Jager, L.P. Aiello, S.C. Patel, and E.T. Cunningham Jr Risks of intravitreous injection: a comprehensive review Retina 24 2004 676 698
2. J.M. Moss, S.R. Sanislo, and C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 2009 1498 1501
3. C.N. Ta Topical antibiotic prophylaxis in intraocular injections Arch Ophthalmol 125 2007 972 974
4. I.U. Scott, and H.W. Flynn Jr The role of topical antibiotic prophylaxis for intravitreal injections Arch Ophthalmol 125 2007 974 976
5. D.G. Hwang Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones Surv Ophthalmol 49 suppl 2004 S79 S83
6. H. Mino de Kaspar, M.J. Koss, and L. He Antibiotic susceptibility of preoperative normal conjunctival bacteria Am J Ophthalmol 139 2005 730 733
7. C.N. Ta, L. He, and H. Mino de Kaspar In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria Eye (Lond) 23 2009 559 560
8. M.J. Koss, M. Eder, and M.S. Blumenkranz The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva [in German] Ophthalmologe 104 2007 21 27
9. V. Jhanji, N. Sharma, G. Satpathy, and J. Titiyal Fourth-generation fluoroquinolone-resistant bacterial keratitis J Cataract Refract Surg 33 2007 1488 1489
10. Y. Hori, T. Nakazawa, and N. Maeda Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones J Cataract Refract Surg 35 2009 475 479
11. J.W. Shell Pharmacokinetics of topically applied ophthalmic drugs Surv Ophthalmol 26 1982 207 218
12. T.M. File Jr Streptococcus pneumoniae and community-acquired pneumonia: a cause of concern Am J Med 117 suppl 2004 39S 50S
13. S.F. Costa, M. Newbaer, and C.R. Santos Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy Int J Antimicrob Agents 17 2001 147 150
14. L.A. Mandell, R.G. Wunderink, and A. Anzueto Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 suppl 2007 S27 S72
15. D.M. Livermore Has the era of untreatable infections arrived? J Antimicrob Chemother 64 suppl 2009 i29 i36
16. C.J. Fernandes, L.A. Fernandes, P. Collignon Australian Group on Antimicrobial Resistance Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus J Antimicrob Chemother 55 2005 506 510
17. T.J. Liesegang Use of antimicrobials to prevent postoperative infection in patients with cataracts Curr Opin Ophthalmol 12 2001 68 74
18. C.N. Ta, P.R. Egbert, and K. Singh Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery Ophthalmology 109 2002 2036 2041
19. J.M. Moss, D. Nguyen, and Y.I. Liu Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora Ophthalmology 115 2008 2013 2016
20. S.M. Hariprasad, W.F. Mieler, and E.R. Holz Vitreous and aqueous penetration of orally administered gatifloxacin in humans Arch Ophthalmol 121 2003 345 350
21. S.M. Hariprasad, K.J. Blinder, and G.K. Shah Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous Arch Ophthalmol 123 2005 39 44
22. S.M. Hariprasad, G.K. Shah, and W.F. Mieler Vitreous and aqueous penetration of orally administered moxifloxacin in humans Arch Ophthalmol 124 2006 178 182
23. C.N. Ta, R.T. Chang, and K. Singh Antibiotic resistance patterns of ocular bacteria flora: a prospective study of patients undergoing anterior segment surgery Ophthalmology 110 2003 1946 1951
24. J.L. Chung, K.Y. Seo, and D.E. Yong Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients Ophthalmology 116 2009 1067 1074
25. N. Hautala, M. Koskela, and T. Hautala Major age group-specific differences in conjunctival bacteria and evolution of antimicrobial resistance revealed by laboratory data surveillance Curr Eye Res 33 2008 907 911
26. D.P. Han, S.R. Wisniewski, and L.A. Wilson Spectrum and susceptibilities of microbiological isolates in the Endophthalmitis Vitrectomy Study Am J Ophthalmol 122 1996 1 17
27. T.L. Bannerman, D.L. Rhoden, S.K. Mcallister Endophthalmitis Vitrectomy Study Group The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study: a comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis Arch Ophthalmol 115 1997 357 361
28. J.K. Leong, R. Shah, and P.J. McCluskey Bacterial contamination of the anterior chamber during phacoemulsification cataract surgery J Cataract Refract Surg 28 2002 826 833
29. I. Morrissey, R. Burnett, L. Viljoen, and M. Robbins Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002 J Infect 49 2004 109 114
30. D.C. Hooper Fluoroquinolone resistance among Gram-positive cocci Lancet Infect Dis 2 2002 530 538
31. M.K. Bolon The newer fluoroquinolones Infect Dis Clin North Am 23 2009 1027 1051 x
32. R.P. Kowalski, L.M. Karenchak, and A.W. Eller The role of ciprofloxacin in endophthalmitis therapy Am J Ophthalmol 116 1993 695 699
33. S.S. Lane, R.H. Osher, S. Masket, and S. Belani Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery J Cataract Refract Surg 34 2008 1451 1459
34. D. Miller, P.M. Flynn, and I.U. Scott In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates Arch Ophthalmol 124 2006 479 483
35. C. Chiquet, A. Pechinot, C. Creuzot-Garcher French Institutional Endophthalmitis Study Group Acute postoperative endophthalmitis caused by Staphylococcus lugdunensis J Clin Microbiol 45 2007 1673 1678
36. A. Pinna, S. Zanetti, and M. Sotgiu Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections Br J Ophthalmol 83 1999 771 773
37. H. Mino de Kaspar, A.S. Hoepfner, and M. Engelbert Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model Ophthalmology 108 2001 470 478
38. M.G. Speaker, F.A. Milch, and M.K. Shah Role of external bacteria flora in the pathogenesis of acute postoperative endophthalmitis Ophthalmology 98 1991 639 649
39. J.J. de Caro, C.N. Ta, and H.K. Ho Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections Retina 28 2008 877 883
40. S.D. Chen, Q. Mohammed, B. Bowling, and C.K. Patel Vitreous wick syndrome - a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana [letter] Am J Ophthalmol 137 2004 1159 1160
41. R.K. Shockley, W.M. Jay, and P.H. Fishman Effect of inoculum size on the induction of endophthalmitis in aphakic rabbit eyes Acta Ophthalmol (Copenh) 63 1985 35 38
42. A.R. Bhavsar, J.M. Googe Jr, and C.R. Stockdale Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 2009 1581 1583
43. M.C. Callegan, B.D. Novosad, and R.T. Ramadan Rate of bacterial eradication by ophthalmic solutions of fourth generation fluoroquinolones Adv Ther 26 2009 447 454